Verve Therapeutics, Inc closed the private placement of 2,296,317 shares at an issue price of price of $10 per share on December 1, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.01 USD | -5.50% | -6.24% | -56.89% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
760 USD | -1.50% | +3.41% | 684B | ||
6.01 USD | -5.50% | -6.24% | 505M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.89% | 505M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- VERV Stock
- News Verve Therapeutics, Inc.
- Verve Therapeutics, Inc. announced that it has received $22.96317 million in funding from Eli Lilly and Company